Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

FHS
May 16, 2024
12:09 pm

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

Study tests recast therapy for bilingual children with developmental language disorder

Amanda Owen Van Horne sits on the floor while a child mixes up cake batter in a play kitchen.

October 20, 2023

FDA questions off-target edit testing on Vertex and CRISPR’s potential sickle cell gene therapy ahead of adcomm

The FDA is convening an advisory committee next Tuesday to discuss whether Vertex Pharmaceuticals and CRISPR Therapeutics did enough to adequately measure the off-target alterations

October 28, 2023

Natural bioactive molecules can relieve cold and flu symptoms

Researchers at Applied Biological Laboratories Inc. discovered how natural bioactive molecules can effectively relieve cold and flu symptoms by protecting the mucosal barrier function and

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.